Therapeutics vs. Vaccination
Stacey discusses the complexities of using monoclonal therapies as alternatives or complements to vaccination, emphasizing their operational challenges and costs. She highlights the importance of vaccination as a primary public health strategy, especially in heavily infected areas, while cautioning against relying on unproven drugs that lack substantial data. The conversation also touches on the ongoing debate surrounding risk assessment in choosing between vaccination and exposure to variants like Delta.In this clip
From this podcast
Commune with Jeff Krasno
217. The Nuances of Delta and Vaccine Efficacy with Dr. Stacey Klutts
Related Questions